80 related articles for article (PubMed ID: 304178)
1. Ferritin and depressed lymphocytes in breast cancer.
Whitehead RH; Roberts GP; Worwood M
N Engl J Med; 1978 Feb; 298(5):280. PubMed ID: 304178
[No Abstract] [Full Text] [Related]
2. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer.
Moroz C; Kupfer B
Isr J Med Sci; 1981; 17(9-10):879-81. PubMed ID: 6458580
[TBL] [Abstract][Full Text] [Related]
3. The significance of ferritin in malignant diseases.
Giler S; Moroz C
Biomedicine; 1978; 28(4):203-6. PubMed ID: 737272
[TBL] [Abstract][Full Text] [Related]
4. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
[No Abstract] [Full Text] [Related]
5. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
Shukla HS; Whitehead RH; Hughes LE
Clin Oncol; 1980 Mar; 6(1):39-47. PubMed ID: 6966205
[No Abstract] [Full Text] [Related]
6. [Relation of blood serum ferritin and ferritin-bearing lymphocytes in breast cancer].
Chernovskaia EM; Polevaia EB; Tuzhikova NK
Med Radiol (Mosk); 1986 Apr; 31(4):15-7. PubMed ID: 3959805
[TBL] [Abstract][Full Text] [Related]
7. Immunodiagnostic test for the early detection of carcinoma of the breast.
Giler S; Kupfer B; Urca I; Moroz C
Surg Gynecol Obstet; 1979 Nov; 149(5):655-7. PubMed ID: 315619
[TBL] [Abstract][Full Text] [Related]
8. Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.
Pattanapanyasat K; Hoy TG; Jacobs A; Courtney S; Webster DJ
Br J Cancer; 1988 Feb; 57(2):193-7. PubMed ID: 2965916
[TBL] [Abstract][Full Text] [Related]
9. T and B lymphocytes in cancer patients.
Sengupta U; Dutta TK; Gupta BD; Aikat BK
Indian J Cancer; 1978 Jun; 15(2):6-9. PubMed ID: 312245
[No Abstract] [Full Text] [Related]
10. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
Olusi SO; Oluwole SF; Odesanmi WO
Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
[TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in breast cancer].
Polevaia EB; Tkacheva GA; Letiagin VP; Ivanov VM; Koposova TL
Sov Med; 1985; (3):25-9. PubMed ID: 4023831
[No Abstract] [Full Text] [Related]
12. A study of T-cell population in carcinoma breast.
Nirwan PS; Ramdeo IN; Solanki RL
Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
[No Abstract] [Full Text] [Related]
13. [Expression of surface markers of lymphocytes and their relation to suppressor function in lymphogranulomatosis].
Tabagari DZ; Chernovskaia EM; Kadagidze ZG
Eksp Onkol; 1985; 7(2):60-4. PubMed ID: 3159562
[TBL] [Abstract][Full Text] [Related]
14. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
[TBL] [Abstract][Full Text] [Related]
15. [Disorders of the immune system in benign lesions and cancer of the breast].
Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer.
N Engl J Med; 1977 May; 296(20):1172-4. PubMed ID: 323704
[No Abstract] [Full Text] [Related]
17. [Hormonal and immunological changes in breast cancers with different growth rates].
Balmukhanov SB; Zhalgasbaeva GT; Kurralasov AK; Baisheva SA; Togaĭbaeva ZI
Vopr Onkol; 1989; 35(11):1319-22. PubMed ID: 2609521
[TBL] [Abstract][Full Text] [Related]
18. Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins.
Hann HW; Stahlhut MW; Evans AE
Prog Clin Biol Res; 1985; 175():331-45. PubMed ID: 3873075
[TBL] [Abstract][Full Text] [Related]
19. Placental isoferritin-associated p43 in pregnancy and breast cancer. Minireview.
Rosen HR
Neoplasma; 1996; 43(6):357-62. PubMed ID: 8996558
[TBL] [Abstract][Full Text] [Related]
20. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
Strache RR; Büttner HH; Kunze M; Röpcke G
Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
